









Mercado
/
Acciones
/
nasdaq-qdel
/

QuidelOrtho Corp

QDEL

26.990USD

+0.180+0.67%

Cierre 10/31, 16:00（ET）Cotizaciones retrasadas 15 min

1.83BCap. mercado

PérdidaP/E TTM



QuidelOrtho Corp

26.990

+0.180+0.67%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de QuidelOrtho Corp Compañía

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Información de QuidelOrtho Corp



Símbolo de cotizaciónQDEL

Nombre de la empresaQuidelOrtho Corp

Fecha de salida a bolsaFeb 01, 1991

Director ejecutivoMr. Brian J. Blaser

Número de empleados6600

Tipo de seguridadOrdinary Share

Fin del año fiscalFeb 01

Dirección9975 Summers Ridge Road

CiudadSAN DIEGO

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal92121

Teléfono18585521100

Sitio Webhttps://www.quidelortho.com/

Símbolo de cotizaciónQDEL

Fecha de salida a bolsaFeb 01, 1991

Director ejecutivoMr. Brian J. Blaser

Ejecutivos de QuidelOrtho Corp



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.40K

+0.65%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

11.45K

Mr. John R. Chiminski

Independent Director

2.52K

Sergio Gadaleta

Senior Vice President - Clinical and Regulatory Affairs

Devon Burek

Senior Vice President - Global Quality

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.40K

+0.65%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Labs

369.70M

60.22%

Immunohematology

132.30M

21.55%

Point-of-Care

93.00M

15.15%

Donor Screening

13.30M

2.17%

Molecular Diagnostic Solutions

5.60M

0.91%

Por regiónUSD

Nombre

Ganancia

Proporción

North America

310.70M

50.61%

Other

132.50M

21.58%

EMEA

87.30M

14.22%

China

83.40M

13.59%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Labs

369.70M

60.22%

Immunohematology

132.30M

21.55%

Point-of-Care

93.00M

15.15%

Donor Screening

13.30M

2.17%

Molecular Diagnostic Solutions

5.60M

0.91%

Estadísticas de accionistas

Actualizado: mié., 8 de oct

Accionistas

Tipos de accionistas

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

16.40%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

State Street Investment Management (US)

3.98%

Otro

47.69%

Accionistas

Proporción

T. Rowe Price Investment Management, Inc.

16.40%

BlackRock Institutional Trust Company, N.A.

13.67%

The Vanguard Group, Inc.

11.44%

Rubric Capital Management LP

6.83%

State Street Investment Management (US)

3.98%

Otro

47.69%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

64.70%

Investment Advisor/Hedge Fund

33.01%

Hedge Fund

14.79%

Research Firm

2.13%

Pension Fund

1.21%

Individual Investor

0.94%

Private Equity

0.69%

Bank and Trust

0.65%

Sovereign Wealth Fund

0.52%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

654

80.03M

117.86%

-21.61M

2025Q2

684

78.51M

115.63%

-21.42M

2025Q1

726

76.59M

113.26%

-21.60M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

T. Rowe Price Investment Management, Inc.

11.14M

16.4%

-310.96K

-2.72%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

9.28M

13.67%

+1.73M

+22.86%

Jun 30, 2025

The Vanguard Group, Inc.

7.77M

11.44%

+1.04M

+15.55%

Jun 30, 2025

Rubric Capital Management LP

4.64M

6.83%

-1.50M

-24.47%

Jun 30, 2025

State Street Investment Management (US)

2.70M

3.98%

+510.29K

+23.29%

Jun 30, 2025

Fidelity Management & Research Company LLC

2.56M

3.76%

+1.30M

+103.23%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.51M

3.69%

+691.35K

+38.04%

Jun 30, 2025

D. E. Shaw & Co., L.P.

2.01M

2.96%

+663.57K

+49.41%

Jun 30, 2025

American Century Investment Management, Inc.

1.92M

2.82%

+327.00K

+20.58%

Jun 30, 2025

AQR Capital Management, LLC

1.82M

2.68%

-838.33K

-31.57%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

1.67%

Invesco S&P SmallCap Health Care ETF

1.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.64%

JPMorgan Fundamental Data Science Small Core ETF

0.37%

Ballast Small/Mid Cap ETF

0.33%

SPDR S&P 600 Small Cap Value ETF

0.27%

iShares S&P Small-Cap 600 Value ETF

0.27%

Avantis US Small Cap Value ETF

0.27%

iShares U.S. Medical Devices ETF

0.22%

Avantis US Small Cap Equity ETF

0.2%

SPDR S&P Health Care Equipment ETF

Proporción1.67%

Invesco S&P SmallCap Health Care ETF

Proporción1.28%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción0.64%

JPMorgan Fundamental Data Science Small Core ETF

Proporción0.37%

Ballast Small/Mid Cap ETF

Proporción0.33%

SPDR S&P 600 Small Cap Value ETF

Proporción0.27%

iShares S&P Small-Cap 600 Value ETF

Proporción0.27%

Avantis US Small Cap Value ETF

Proporción0.27%

iShares U.S. Medical Devices ETF

Proporción0.22%

Avantis US Small Cap Equity ETF

Proporción0.2%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

